A detailed history of Newbridge Financial Services Group, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 300 shares of TMDX stock, worth $18,795. This represents 0.02% of its overall portfolio holdings.

Number of Shares
300
Previous 300 -0.0%
Holding current value
$18,795
Previous $45,000 4.44%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

SELL
$53.63 - $82.33 $5,363 - $8,233
-100 Reduced 25.0%
300 $22,000
Q1 2021

Sep 07, 2021

BUY
$17.75 - $47.82 $7,100 - $19,128
400 New
400 $17,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.99B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Newbridge Financial Services Group, Inc. Portfolio

Follow Newbridge Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.